Zynex

Company Description

Zynex, Inc. is a medical technology company specializing in non-invasive medical devices for pain management, rehabilitation, and patient monitoring. Its main businesses include Zynex Medical Products (NexWave, NeuroMove, InWave, E-Wave, M-Wave), Private Labeled Supplies (Electrodes, Batteries), Private Labeled Rehabilitation Products (Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing, Dynacomp), and Zynex Monitoring Solutions Products (CM-1500, CM-1600, NiCO CO-Oximeter, HemeOx tHb Oximeter). No specific regions of operation are mentioned in the description. In the last fiscal year, the company had 1000 employees, a market cap of $68 million, profits of $153 million, and revenue of $192 million.

Analysis

ANALYSIS: With an Obermatt 360° View of 1 (better than 1% compared with alternatives), overall professional sentiment and financial characteristics for the stock Zynex are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with all four indicators below average for Zynex. The consolidated Value Rank has a low rank of 48 which means that the share price of Zynex is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 52% of alternative stocks in the same industry. The consolidated Growth Rank also has a low rank of 1, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is lower than for 1% of competitors in the same industry. The consolidated Safety Rank has a riskier rank of 6, which means that the company has a riskier financing structure than 94% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a low rank of 4, which means that professional investors are more pessimistic about the stock than for 96% of alternative investment opportunities. ...read more

Country

USA

Industry Health Care Equipment

Size X-Small

Website zynex.com

Index

NASDAQ

Add to Watchlist

See Similar Stocks

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.